Nchi: Australia
Lugha: Kiingereza
Chanzo: APVMA (Australian Pesticides and Veterinary Medicines Authority)
EQUINE HERPES VIRUS 1 (EHV-1) 438/77 STRAIN; EQUINE HERPES VIRUS 4 (EHV-4) 405/76 STRAIN
ZOETIS AUSTRALIA PTY LTD
EHV-1+EHV-4
PARENTERAL LIQUID/SOLUTION/SUSPENSION
EQUINE HERPES VIRUS 1 (EHV-1) 438/77 STRAIN VACCINE Active 0.0 P; EQUINE HERPES VIRUS 4 (EHV-4) 405/76 STRAIN VACCINE Active 0.0 P
10 x 1dose; Vial=1.5mL
VM - Veterinary Medicine
ZOETIS AUSTRALIA
HORSE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT STUD | MARE | PACER | POL
IMMUNOTHERAPY
ANTIBIOTIC - ANTI-INFECTIVE | ABRASIONS | ABSCESSES | AIRSACCULITIS | ANTISEPTIC | AVIAN MYCOPLASMAS | BLACKHEAD | BODY ODOURS | BOWED TENDONS | BROAD SPECTRUM | BURNS | COCCIDIOSIS | COLIFORM COMPLEX | CONJUNCTIVITIS | COWPOX | CRACKS | CRUSTS | DANDRUFF | DERMATOLOGICAL DISORDERS | DERMATOSIS | DRY SKIN | DYSENTERY | ECZEMA | ENDOMETRITIS | ENTERIC DISEASES | ENZOOTIC PNEUMONIA | FEED EFFICIENCY | FUNGAL INFECTIONS | GIRTH GALLS | INFECTIONS | INFLAMMED PADS | ITCHING | KERATOLYTIC | LACERATIONS | MASTITIS | MYCOPLASMAS | ODOURS | OPEN WOUNDS | OTITIS | PRURITIS | QUEENSLAND ITCH | RESPIRATORY DISEASE | SADDLE RASH | SALMONELLOSIS | SCABS | SCALY SKIN | SHEATH ROT | SKIN IRRITATIONS | SORES | SWINE DYSENTERY | TEAT CRACKING | TEAT INFECTIONS | TOPICAL INFECTIONS | UDDER SORES | WEIGHT GAIN | WIRE CUTS | WOUNDS
Poison schedule: 0; Withholding period: Zero (0) days; Host/pest details: HORSE: [ANTIBIOTIC - ANTI-INFECTIVE]; Poison schedule: 0; Withholding period: WHP: MEAT:Nil.; Host/pest details: HORSE: [ANTIBIOTIC - ANTI-INFECTIVE]; Poison schedule: 0; Withholding period: ; Host/pest details: HORSE: [ANTIBIOTIC - ANTI-INFECTIVE]; For the vaccination of horses and ponies for reduction in the clinical signs of the respiratory diseases caused by EHV-1 and EHV-4. For use as an aid in the control of EHV-1 abortion when used in conjunction with appropriate management practices.Animals that have received immunosuppressive drugs (eg. glucocorticoids) should not be vaccinated until an interval of at least 4 weeks has elapsed.
Registered
2023-07-01
. ' APPENDIX 2 AUSTRALIAN GOVERNMENT AUSTRALIAN PESTICIDES AND VETERINARY MEDICINES ANTHORITY TEMPLATE FOR RELEVANT LABEL PARTICULARS (RLPS) (VETERINARY PRODUCTS) Select appropriate: 0 New Product (include all applicable RLPs) OR 0 Variation (highlight instructions that are being varied). Approval no. of label being varied: 48485/0507. Signal heading: Product name: Active constituenl/s: Statement of claims: Net contents: Directions for Use Heading: Restraints: Contraindications: PRECAUTIONS: Side effects: Dosage & ADMINISTRATION: + RLP Approved FOR ANIMAL TREATMENT ONLY DUVAXYN® EHV 1,4 INACTIVATED ADJUVANTED EQUINE HERPES VACCINE DUVAXYN® EHV 1 , 4 is an inactivated adjuvanted liquid vaccine in a glass vial and presented in a form for administration to horses and ponies. Each single vial contains one dose (1.5 ml) of an inactivated aqueous solution of equine herpesvirus 1 (EHV-1. RP~1) and equine herpesvirus 4 (EHV-4, RP~1) grown on continuous cell lines. The adjuvant carbomer is used in the formulation to stimulate the immune system. For the vaccination of healthy horses and ponies for reduction in the clinical signs of the respiratory diseases caused by EHV-1 and EHV-4. For use as an aid in the control of EHV-1 abortion when used in conjunction with appropriate management practices. Pregnant mares vaccinated with this product may still abort. 10 x 1 dose (1.5ml) vials READ ATTACHED LEAFLET BEFORE USING THIS PRODUCT DIRECTIONS FOR USE FOR USE BY OR UNDER THE DIRECT SUPERVISION OF A REGISTERED VETERINARY SURGEON. N/A Do not vaccinate sick horses and ponies. Animals that have received immunosuppressive drugs (eg glucocorticoids) should not be vaccinated until an interval of at least 4 weeks has elapsed. The vaccine is safe for administration to pregnant mares but the handling of mares during pregnancy carries its own inherent risks. After administration of any vaccine, a systemic reaction can occasionally occur. Local reactions may occur following vaccination and are usually transient. In cases of local reactio Soma hati kamili
Product Name: Duvaxyn® EHV 1,4 Inactivated Adjuvanted Equine Herpes Vaccine Page: 1 of 4 This revision issued: October, 2015 SAFETY DATA SHEET Issued by: Zoetis Australia Pty Ltd Phone: 1800 814 883 POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800 764 766 IN NEW ZEALAND) SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER ZOETIS AUSTRALIA PTY LTD ABN 94 156 476 425 Level 6, 5 Rider Blvd Rhodes NSW 2138 AUSTRALIA Tel: 1800 814 883 Fax: (02) 8876 0444 Email: australia.animalhealth@zoetis.com CHEMICAL NATURE: Suspension of equine herpes virus (inactivated). TRADE NAME: DUVAXYN ® EHV 1,4 INACTIVATED ADJUVANTED EQUINE HERPES VACCINE OTHER NAMES: Duvaxyn EHV APVMA CODE: 48485 PRODUCT USE: Vaccination of horses against disease caused by equine herpes viruses. CREATION DATE: JULY, 2012 THIS VERSION ISSUED: OCTOBER, 2015 and is valid until December, 2017. SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: Not Hazardous - No criteria found. SUSMP CLASSIFICATION: None allocated. ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated E E E M M M E E E R R R G G G E E E N N N C C C Y Y Y O O O V V V E E E R R R V V V I I I E E E W W W PHYSICAL DESCRIPTION & COLOUR : Duvaxyn EHV1,4 is presented in glass vials containing 1.5 ml (1 dose). ODOUR: No data. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. P P P O O O T T T E E E N N N T T T I I I A A A L L L H H H E E E A A A L L L T T T H H H E E E F F F F F F E E E C C C T T T S S S NOTE: DIFFERENT HAZARD ASSESSMENT CRITERIA OF SWA AND TGA MAY RESULT IN SEEMING INCONSISTENCIES BETWEEN MSDS AND LABEL. EFFECTS DESCRIBED IN THIS MSDS RELATE TO SHORT TERM EMERGENCY SITUATIONS, SUCH AS ACCIDENTS AND SPILLS WITH THE POTENTIAL FOR GRO Soma hati kamili